Back to User profile » Dr Sheng Hu Wu
Papers published by Dr Sheng Hu Wu:
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/w2XcPgkthPw/1.jpg)
Wang G, Cheng Y, Wang JN, Wu SH, Xue HB
Neuropsychiatric Disease and Treatment 2016, 12:2077-2087
Published Date: 22 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
Treuer T, Méndez L, Montgomery W, Wu S
Neuropsychiatric Disease and Treatment 2016, 12:1061-1083
Published Date: 3 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H
Neuropsychiatric Disease and Treatment 2014, 10:1287-1296
Published Date: 10 July 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia
Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, Haro JM
Patient Preference and Adherence 2013, 7:987-995
Published Date: 30 September 2013